journal article·2019-09Open access

Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies

Mireia Pesarrodona, Toni Jauset, Zamira V. Díaz‐Riascos, Alejandro Sánchez‐Chardi, Marie‐Eve Beaulieu, Joaquin Seras‐Franzoso, Laura Sánchez‐García, Ricardo Baltà‐Foix, Sandra Mancilla, Yolanda Fernández, Ursula Rinas, Simó Schwartz, Laura Soucek, Antonio Villaverde, Ibane Abasolo, Esther Vázquez

Advanced Science· Volume 6· Issue 18

Abstract

Abstract Two structurally and functionally unrelated proteins, namely Omomyc and p31, are engineered as CD44‐targeted inclusion bodies produced in recombinant bacteria. In this unusual particulate form, both types of protein materials selectively penetrate and kill CD44+ tumor cells in culture, and upon local administration, promote destruction of tumoral tissue in orthotropic mouse models of human breast cancer. These findings support the concept of bacterial inclusion bodies as versatile protein materials suitable for application in chronic diseases that, like cancer, can benefit from a local slow release of therapeutic proteins.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Bacteriophages and microbial interactions · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut de Biotecnologia i de Biomedicina Universitat Autònoma de Barcelona Bellaterra 08193 Barcelona Spain

CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER‐BBN) C/ Monforte de Lemos 3‐5 28029 Madrid Spain

Vall d'Hebron Institute of Oncology (VHIO) Edifici Cellex Hospital Vall d'Hebron 08035 Barcelona Spain

Peptomyc S.L. Edifici Cellex Hospital Vall d'Hebron 08035 Barcelona Spain

Functional Validation & Preclinical Research CIBBIM‐Nanomedicine Vall d'Hebron Institut de Recerca (VHIR) Universitat Autònoma de Barcelona 08035 Barcelona Spain

Drug Delivery & Targeting CIBBIM‐Nanomedicine Vall d'Hebron Institut de Recerca (VHIR) Universitat Autònoma de Barcelona 08035 Barcelona Spain

Departament de Biologia Evolutiva Ecologia i Ciències Ambientals Facultat de Biologia Universitat de Barcelona Av. Diagonal 643 08028 Barcelona Spain

Departament de Genètica i de Microbiologia Universitat Autònoma de Barcelona Bellaterra 08193 Barcelona Spain

Leibniz University of Hannover Technical Chemistry and Life Science Callinstr. 5 30167 Hannover Germany

Helmholtz Centre for Infection Research Inhoffenstraße 7 38124 Braunschweig Germany

Institució Catalana de Recerca i Estudis Avançats (ICREA) 08010 Barcelona Spain

Department of Biochemistry and Molecular Biology Universitat Autònoma de Barcelona Bellaterra 08193 Barcelona Spain

Funding

European Regional Development Fund · Agencia Estatal de Investigación · Instituto de Salud Carlos III · Agència de Gestió d’Ajuts Universitaris i de Recerca · European Research Council · Albert Einstein Cancer Center · Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina · Federación Española de Enfermedades Raras

References (82)

Show source-provided references
1. 10.1093/femsre/fuy03810.1093/femsre/fuy038 ↗
2. 10.1371/journal.pbio.006019510.1371/journal.pbio.0060195 ↗
3. 10.4161/pri.3.3.992210.4161/pri.3.3.9922 ↗
4. 10.1016/j.actbio.2012.11.03310.1016/j.actbio.2012.11.033 ↗
5. 10.1002/adma.20090028310.1002/adma.200900283 ↗
6. 10.1186/1475-2859-11-7610.1186/1475-2859-11-76 ↗
7. 10.1038/nbt0707-71810.1038/nbt0707-718 ↗
8. 10.1007/978-1-4939-2205-5_2410.1007/978-1-4939-2205-5_24 ↗
9. 10.1186/s12934-019-1081-510.1186/s12934-019-1081-5 ↗
10. 10.1002/adma.20110433010.1002/adma.201104330 ↗
11. 10.1039/C5SM02930A10.1039/C5SM02930A ↗
12. 10.1186/1475-2859-11-6710.1186/1475-2859-11-67 ↗
13. 10.1186/1475-2859-12-1610.1186/1475-2859-12-16 ↗
14. 10.1186/s12934-018-0904-010.1186/s12934-018-0904-0 ↗
15. 10.1016/j.jconrel.2018.04.00410.1016/j.jconrel.2018.04.004 ↗
16. 10.1038/srep3576510.1038/srep35765 ↗
17. 10.1126/science.117315510.1126/science.1173155 ↗
18. 10.1126/scisignal.280pe4310.1126/scisignal.280pe43 ↗
19. 10.1371/journal.ppat.100274410.1371/journal.ppat.1002744 ↗
20. 10.1016/j.ibmb.2011.11.01110.1016/j.ibmb.2011.11.011 ↗
21. 10.3389/fmicb.2014.0040110.3389/fmicb.2014.00401 ↗
22. Romero D. · Int. Microbiol. · 2014 · 17 · 65
23. 10.1128/MCB.00073-1410.1128/MCB.00073-14 ↗
24. 10.1074/jbc.M114.61381010.1074/jbc.M114.613810 ↗
25. 10.1016/j.devcel.2016.10.00510.1016/j.devcel.2016.10.005 ↗
26. 10.3390/biology501000210.3390/biology5010002 ↗
27. 10.1111/mmi.1321910.1111/mmi.13219 ↗
28. 10.1038/srep2542510.1038/srep25425 ↗
29. 10.3390/biom704007110.3390/biom7040071 ↗
30. 10.3390/biom703006010.3390/biom7030060 ↗
31. 10.3390/biom703004510.3390/biom7030045 ↗
32. 10.3390/biom703004610.3390/biom7030046 ↗
33. 10.1099/mic.0.00044310.1099/mic.0.000443 ↗
34. 10.1016/j.jmb.2018.07.01010.1016/j.jmb.2018.07.010 ↗
35. 10.1002/ijc.2166210.1002/ijc.21662 ↗
36. 10.1074/jbc.M31202620010.1074/jbc.M312026200 ↗
37. 10.1038/sj.onc.120219910.1038/sj.onc.1202199 ↗
38. 10.3389/fcell.2017.0001010.3389/fcell.2017.00010 ↗
39. 10.1038/nature0726010.1038/nature07260 ↗
40. 10.1101/gad.205542.11210.1101/gad.205542.112 ↗
41. 10.1101/gad.203841110.1101/gad.2038411 ↗
42. 10.1016/j.ejca.2010.02.02410.1016/j.ejca.2010.02.024 ↗
43. 10.1053/j.gastro.2015.10.02010.1053/j.gastro.2015.10.020 ↗
44. 10.1002/jcp.104160020910.1002/jcp.1041600209 ↗
45. 10.1242/jcs.0262910.1242/jcs.02629 ↗
46. 10.1186/bcr161010.1186/bcr1610 ↗
47. 10.1634/theoncologist.2011-S1-0110.1634/theoncologist.2011-S1-01 ↗
48. 10.1016/j.ijpharm.2014.07.01610.1016/j.ijpharm.2014.07.016 ↗
49. 10.3390/ijms1211827510.3390/ijms12118275 ↗
50. 10.1088/0957-4484/21/20/20510110.1088/0957-4484/21/20/205101 ↗
51. 10.1038/bjc.2013.80910.1038/bjc.2013.809 ↗
52. 10.1088/0957-4484/28/1/01510210.1088/0957-4484/28/1/015102 ↗
53. 10.1016/S0304-3835(00)00586-310.1016/S0304-3835(00)00586-3 ↗
54. 10.1074/jbc.M20496220010.1074/jbc.M204962200 ↗
55. 10.1016/j.canlet.2008.02.01410.1016/j.canlet.2008.02.014 ↗
56. Sheikh M. S. · Oncogene · 1995 · 11 · 1899
57. Kondo S. · Oncogene · 1996 · 13 · 1279
58. 10.1002/adhm.20150040210.1002/adhm.201500402 ↗
59. 10.1016/j.jsb.2017.10.01210.1016/j.jsb.2017.10.012 ↗
60. 10.1146/annurev-biophys-070816-03392810.1146/annurev-biophys-070816-033928 ↗
61. 10.1021/acs.biomac.9b0022810.1021/acs.biomac.9b00228 ↗
62. 10.1021/acsami.5b0607610.1021/acsami.5b06076 ↗
63. 10.1016/j.colsurfb.2015.04.01710.1016/j.colsurfb.2015.04.017 ↗
64. 10.1016/j.tibs.2017.01.00510.1016/j.tibs.2017.01.005 ↗
65. 10.1371/journal.pone.016407310.1371/journal.pone.0164073 ↗
66. 10.1016/j.actbio.2013.12.02110.1016/j.actbio.2013.12.021 ↗
67. 10.2217/nnm.15.510.2217/nnm.15.5 ↗
68. 10.1016/j.tibtech.2011.09.00310.1016/j.tibtech.2011.09.003 ↗
69. 10.1177/194760191037802410.1177/1947601910378024 ↗
70. 10.1126/scitranslmed.aar501210.1126/scitranslmed.aar5012 ↗
71. 10.1038/s41388-018-0421-y10.1038/s41388-018-0421-y ↗
72. 10.1002/path.518210.1002/path.5182 ↗
73. 10.2174/092986652366616122215044410.2174/0929866523666161222150444 ↗
74. Reichert J. M. · Curr. Opin. Mol. Ther. · 2003 · 5 · 139
75. 10.1038/clpt.2013.11710.1038/clpt.2013.117 ↗
76. Butler T. · P T · 2015 · 40 · 191
77. 10.1016/j.nano.2015.07.00910.1016/j.nano.2015.07.009 ↗
78. 10.1371/journal.pone.005310910.1371/journal.pone.0053109 ↗
79. 10.1074/jbc.M110.11454610.1074/jbc.M110.114546 ↗
80. 10.1038/onc.2015.38110.1038/onc.2015.381 ↗
81. 10.1016/j.ccell.2016.02.00210.1016/j.ccell.2016.02.002 ↗
82. 10.18632/oncotarget.891310.18632/oncotarget.8913 ↗